Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of Lycium barbarum polysaccharide-glycoprotein(LBP) on irradiated HaCaT cells

ABSTRACT: To investigate the protective effect of Lycium barbarum polysaccharide-glycoprotein (LBP) in the radiation-induced HaCaT cell injury, We performed gene expression profiling analysis using data obtained from RNA-seq of HaCaT cells at 3h after radiation.

ORGANISM(S): Homo sapiens

PROVIDER: GSE218507 | GEO | 2024/06/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Effect of Lycium barbarum polysaccharide-glycoprotein(LBP) on irradiated HaCaT cells

Project description:Effect of Lycium barbarum polysaccharide-glycoprotein(LBP) on irradiated HaCaT cells

| PRJNA904030 | ENA

Anther transcriptome analysis of Lycium barbarum at different developmental stages

Project description:The causes of male sterility of Lycium barbarum were analyzed by comparing the anther transcriptomes of fertile and sterile lines

2025-07-23 | GSE236751 | GEO

Lycium barbarum polysaccharide-glycoprotein ameliorates abnormal neural activity in depressive patient-derived ventral forebrain organoids

Project description:Major depressive disorder (MDD) is a severe mood disorder that imposes a significant burden on individuals, families, and society. Despite considerable advances in research, most current treatments for depression remain ineffective for many patients. Given the potential antidepressant properties of Lycium barbarum glycopeptide (LbGp), there is an urgent need to establish a platform for evaluating its therapeutic efficacy and underlying mechanisms. In this study, we generated ventral forebrain organoids derived from MDD patient and observed abnormal neuronal morphology along with impaired calcium dynamics and electrical activity. Treatment with LbGp effectively restored these phenotypic alterations in MDD organoids. Transcriptomic analysis further revealed that LbGp could ameliorate endoplasmic reticulum (ER) stress in MDD organoids. Furthermore, to investigate the role of ER stress, we treated control organoids with the ER stress agonist CCT020312, which induced similar altered neural activity phenotypes that observed in MDD organoids. Remarkably, LbGp treatment rescued the phenotypic defects in control organoids induced by CCT020312. In conclusion, this study utilized ventral forebrain organoids derived from MDD patients and demonstrated that LbGp ameliorates MDD through the modulation of ER stress.

2025-07-10 | GSE285923 | GEO

Transcriptomic analyses between Lycium barbarum and Lycium ruthenicum

Project description:Lycium barbarum, a member of the Solanaceae family, has been used for more than 2000 years in the traditional Chinese medicine. L. ruthenicum, endemic to northwestern China, is also used as medicine and has had a great influence on the development of Minority Medicine. Previous studies revealed there are many differences between two species, including morphological and phytochemical differences. However, the molecular mechanism of formation of its fruit and associated medicinal and nutritional components is unexplored. In the present studies, for transcriptomic analyses, fruits from 5 developmental stages L. barbarum and L. ruthenicum were collected. KEGG analyses for the DEGs between L. barbarum and L. ruthenicum, revealed that molecular mechanism of fruit formation were distinct obviously during the development process. Moreover, we found that multiple DEGs enriched in “Phenylpropanoid biosynthesis (ID: ko00940”, “Flavonoid biosynthesis” (ID: ko00941) were up-regulated in L. ruthenicum at different developmental stages of fruit. It suggested that biotic and abiotic stress might be responsible for high abundance of antioxidant capacities in L. ruthenicum.

2020-03-23 | GSE122570 | GEO

Lycium barbarum

Project description:Lycium barbarum

| PRJNA317623 | ENA

Lycium barbarum

Project description:Lycium barbarum overview

| PRJNA417525 | ENA

Lycium barbarum

Project description:Lycium barbarum Transcriptome

| PRJNA889209 | ENA

Lycium-barbarum-root

Project description:Chemotyping dataset of n-butanol peptide extract of Lycium barbarum root

2018-06-29 | MSV000082527 | MassIVE

Integration of multiomics reveals the mechanism of Lycium barbarum polysaccharides inhibit MCF-7 cell proliferation

Project description:Background：Breast cancer, as a highly prevalent malignant tumor among women, has a consistently high mortality rate due to metastasis and drug resistance. Lycium barbarum polysaccharides (LBP), which have been reported to have significant anti-tumor activity, have not yet had their molecular mechanism and signaling pathways against breast cancer clearly defined. Methods and Results：In this study, the CCK-8 assay determined that treatment with 8 mg/mL LBP for 48 h was the optimal condition for subsequent multi-omics analysis. The results demonstrated that a high concentration of LBP significantly reduced the viability of MCF-7 cells and inhibited cell proliferation. Transcriptome sequencing revealed that LBP markedly altered the expression levels of the genes HO-1, FTH1, FTL, and TFRC. Metabolomics analysis further indicated that LBP significantly impacted glutathione metabolism, glycerophospholipid metabolism, and the alanine-aspartate-glutamate metabolic pathway. Further integration of transcriptomic and metabolomic data suggests that LBP may suppress cell proliferation by activating the ferroptosis pathway via the NRF2/HO-1 axis. To further validate this hypothesis, we conducted additional experiments to detect the NRF2/HO-1 signaling pathway and markers associated with ferroptosis. The results demonstrated that LBP treatment significantly upregulated the expression of NRF2 and its downstream effector molecule HO-1. Moreover, the specific NRF2 inhibitor ML385 was able to reverse the alterations in GSH, Fe2+, and MDA levels induced by LBP. Conclusion：In conclusion, our research results indicate that LBP induces ferroptosis by activating the NRF2/HO-1 signaling pathway.

2025-07-11 | GSE302164 | GEO

Lycium barbarum

Project description:Lycium barbarum Genome sequencing

| PRJNA541213 | ENA